KAL – Extraordinary Special Meeting of Shareholders
This meeting is simply a vote on a Reverse Split. However, given that management had to release a PR asking shareholders to vote to approve it, it sounds like this […]
This meeting is simply a vote on a Reverse Split. However, given that management had to release a PR asking shareholders to vote to approve it, it sounds like this […]
Quad Witching is when various Futures Contracts and Options Contracts all expire on the same day. When contracts are expiring, often holders of said contracts chose to exercise those contracts […]
When the CEO of a company is interviewed, it is typically a positive engagement. A lot of traders look for events like this, or an interview on TV, to boost […]
This is a vote on a Re-Domiciliation, which is a big word for moving countries. I doubt this becomes an issue, however being in the news and being a shipper […]
Event PR: https://www.bdtonline.com/news/nation_world/belong-acquisition-corp-announces-change-of-special-meeting-date/article_1723ab67-00ae-5e2f-8b0c-478a585f61c4.html
This is the 2nd time CHRS has attempted to submit this to the FDA, which always makes our ears perk up because the company has had to make an extra […]
TGTX has a PDUFA scheduled for this date that includes data they had to submit due to an FDA request for it months earlier. The fact that the FDA asked […]
As of the writing, the website only lists the major companies at the Auto show, which are all the big car companies. We like to use events like this to […]
As far as a catalyst, this ranks up there with Mobile World Congress as being a HUGE event for Event Day traders, and usually big for Runup Traders as well. […]
Note: There are more companies presenting, the Agenda on the website is harder to navigate and there are MANY companies who are not public who are presenting. I will continue […]
The PDUFA is the day that the FDA makes an official decision about whether a drug gets approval or not. Generally speaking, if the company is gets the FDA approval, […]
A "Type A" meeting, in this case, to discuss the contents of a refusal to file letter previously issued regarding the company's New Biologics License Application (BLA) for NurOwn® for the treatment of ALS. While this event is not one that would normally include a "runup" and an "event" type trade, the "Afterglow" traders here […]